Capital Markets Momentum Fades: What it Means for Big Banks in Q3

Third-quarter capital-markets indicators are tracking below consensus expectations, raising the risk that investment-banking and trading revenue estimates for major U.S. banks are too high. July IB volumes fell 6% year over year, driven by an 18% decline in debt capital markets and syndicated lending, although equity capital markets rose 119% and M&A activity increased 11%. Goldman Sachs and Morgan Stanley are most exposed to a capital-markets shortfall, while JPMorgan, Bank of America and Citigroup may be cushioned by diversified revenue streams and 6% year-over-year growth in average loan and deposit balances.

Analysis

The relevant risk is not weak activity but negative estimate revisions: capital-markets franchises are priced on operating leverage, so a modest revenue miss can produce a disproportionate EPS shortfall where compensation and technology costs are less flexible intra-quarter. GS is most exposed to this setup; MS has a partial offset from fee-based wealth revenues, while JPM's earnings mix makes a markets miss less likely to alter full-year FCF expectations or its valuation premium. The cleaner near-term dispersion is therefore GS underperformance versus JPM, rather than a broad bank-sector short.

The apparent balance-sheet cushion should be treated cautiously. Loan growth supports revenue only if yields hold and deposit repricing remains controlled; renewed competition for deposits, a lower front-end rate path, or flatter curves would turn nominal balance growth into weaker NII conversion. BAC has greater sensitivity to this rate/deposit-beta debate than JPM, while C's Services franchise can make its earnings more resilient than its multiple implies if treasury-management balances remain sticky.

Over the next 1-3 months, pre-earnings estimate cuts, management commentary on underwriting backlog conversion, and compensation-accrual guidance matter more than aggregate deal-announcement headlines. The contrarian point is that strong equity issuance and advisory pipelines may support 4Q rather than the reported quarter; investors can overcapitalize those pipelines before revenue recognition. A sustained pickup in credit issuance, or evidence that market-share gains offset industry softness, would quickly invalidate the GS-underperformance thesis. Structurally over 6-18 months, easier financial conditions would favor GS, MS and EVR disproportionately as delayed sponsor and strategic transactions close.

Key Decisions for Investors

• Initiate a 1-3 month pair trade: long JPM / short GS in equal dollar amounts ahead of earnings. Target 8-12% relative return if capital-markets estimates reset; exit if GS guides investment-banking fees or markets revenues above consensus, or if the pair underperforms by 5% from entry.
• Maintain BAC as a watch rather than a long solely on balance-sheet growth. Add only if management demonstrates stable deposit costs and NII guidance resilience; a renewed decline in NII outlook or accelerating deposit beta is the falsifier.
• For a higher-beta recovery expression after any earnings-driven selloff, accumulate MS rather than GS on confirmation that net new assets and fee-based wealth revenues remain intact. This offers a better downside buffer while retaining upside to a 4Q deal-closing rebound; reassess if wealth net flows materially decelerate.
• Avoid using EVR as a short proxy for the broader capital-markets concern: its advisory-heavy model is relatively insulated from debt-underwriting weakness and has the greatest upside torque if announced M&A converts into completed transactions. Instead, set an alert for a material drop in announced M&A or failed deal completion rates before taking a negative view.